Absorption, Distribution, Metabolism, and Elimination (ADME) constitute the fundamental pharmacokinetic processes that govern the fate of drugs within the human body.
Absorption initiates the journey as the drug enters the bloodstream, influenced by factors like formulation and administration route.
Distribution guides the drug to target tissues, determined by blood flow, permeability, and binding characteristics.
Metabolism, predominantly in the liver, transforms the drug into metabolites, facilitating elimination and enhancing water solubility.
Elimination, occurring through renal excretion, hepatic excretion, and other routes, marks the final phase.
Bioavailability, half-life, and first-pass metabolism are pivotal parameters influencing drug efficacy, dosage frequency, and duration of action. The intricate interplay of these processes underscores the concept of pharmacokinetics, essential for comprehending drug behavior. Variability in individual factors, drug interactions, and the emergence of adverse reactions further emphasize the need for meticulous consideration of ADME in drug development and clinical application. Prodrugs and therapeutic drug monitoring underscore the innovative approaches to drug design and optimization, ensuring both efficacy and safety. Regulatory bodies demand a thorough understanding of ADME parameters during drug evaluation, emphasizing its critical role in shaping pharmaceutical landscapes.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Advancing EGFR-targeting macrocyclic peptide-drug conjugates to target KRAS-mutant solid tumors: Design, synthesis, and preclinical evaluations
Akash Panja, Ariel University, Israel